Tackling inflammation in atherosclerotic cardiovascular disease: some thoughts from today's talk at #ESCCongress. 1) Low-dose colchicine can already be added to statin therapy as well as to background therapies that might include multiple other adjunctive lipid lowering agents.

🆕The 2024 Core Curriculum for Structural Heart Disease Interventions. It covers everything from aortic, mitral, and tricuspid procedures to advanced imaging techniques and multidisciplinary patient management. Read more: shorturl.at/SMRj3 #EAPCI #Structuralheartdisease

Coinciding with #ESCCongress 2024, EuroIntervention publishes the Percutaneous Valvular and Structural Heart Disease Interventions Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). This document describes the knowledge, skills, and

#hotline ⁦European Society of Cardiology⁩ #ESCCongress advice to pts: Take your anti-hypertensive meds when it suits you! Relief at last

#ESCCongressVisuals for Hotline 5 POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI? NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation RHEIA - Transcatheter versus surgical aortic

#ESCCongressVisuals for Hotline 7: FINEARTS-HF - #Finerenone in #HeartFailure with mildly reduced and preserved ejection fraction MRAs in #HF - An individual patient data meta-analysis of randomised trials FINE-HEART - Participant-level pooled analysis of finerenone in

#ESCCongressVisuals for Hotline 8: SCOFF - Fasting or no fasting before cardiac catherisation procedures EARTH-STEMI - Complete vs. culprit-only revascularisation in older #STEMI patients SENIOR RITA - Older patients with non-ST segment elevation myocardial infarction

#ESCCongressVisuals for Hotline 9: GUARD-AF - ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals STROKESTOP II - Randomised systematic NT-proBNP and ECG screening for atrial fibrillation among 75 year-olds MIRACLE-AF - A Novel Model of

The one and only Ann Marie Navar delivering “State of The Art “ lecture on Diabetes and CVD. No one better! Brilliant lecture 👏👏👏 JAMA European Society of Cardiology #ESCCongress UT Southwestern Medical Center UTSWdiabetes

CRABL-HF - Cryoballoon 🆚 Radiofrequency Ablation of AF in Patients with #HF #ESCCongress ❄️<1/4 💃🏻 (why?) ❄️no difference in primary endpoint with RF vs CB ❄️LVEF improved in CA with CB & RF at 1 year

🌍 EARTH-STEMI #ESCCongress 🔥 The benefits of complete revascularization now confirmed in older patients with STEMI in an updated IPD meta-analysis 📊 Gianluca Campo Simone Biscaglia European Society of Cardiology European Society of Cardiology Journals #ESC #ESCCongress2024 #Cardiology

In #older pts 7️⃣5️⃣➕ with #NSTEMI, #PCI did not result in ⬇️ risk of #CV #death or #AMI. Though #MI rate during 4yr f-up was ⬆️ in #conservative Rx pts (HR 0.75 95%CI 0.57-0.99) 👉 bit.ly/4dMSTEH #ESCCongress @nejm Professor Vijay Kunadian Davide Capodanno C. Michael Gibson MD Dr Roxana Mehran

Patients will like the #SCOFF trial from #ESCCongress2024! Fasting 🆚nonfasting prior to cath: noninferior priory endpoint (hypotension,aspiration pneumonia, hyperglycemia & hypoglycemia until discharge) Do patients still need to fast pre cath?

📌 #Antithrombotic therapy and body mass: A Consensus Statement of the #ESC Working Groups on Cardiovascular #Pharmacotherapy and #Thrombosis. Discover more in #EHJPharmacotherapy 💊 👉 academic.oup.com/ehjcvp/advance… EHJ-CVP Editor-in-Chief European Society of Cardiology European Society of Cardiology Journals #Cardiology #CardioTwitter

There is one thing that, even as a reviewer and despite having pointed it out during the process, I really haven't understood about the new ESC guidelines for chronic coronary syndromes. Using the new Risk factor-weighted clinical likelihood (RF-CL) model, one can calculate

Davide Capodanno I think the reason is this: when calculating RF-CL, the upper age limit was set to 80. However, 0.6% of the dataset (a synthetic sample was provided in the supplement of the JACC paper, available at this link - vbn.aau.dk/files/33193708…, with 3061 patients) is older than 80 years.

Among of 11,913 patients who underwent platelet function testing (LTA) with a standardized methodology between 2004 and 2022, we found that a significant proportion of individuals present a hyper- or hypo-reactive platelet phenotype. bit.ly/47ffZBz

Pulmonary hypertension (PH) due to left heart disease is the most prevalent cause of PH. It's complex to diagnose & manage, often underdiagnosed in older adults. Accurate testing & early detection are key to better outcomes. More: bit.ly/3XMFeYJ #JACCHF #cvPAH

AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions tctmd.com/news/ai-tool-f…

Beta-Blockers for Secondary Prevention following #MI in Patients Without Reduced Ejection Fraction or #HeartFailure: An Updated Meta-Analysis Meta-analysis of 24 studies (290,349 patients) shows: 📍No significant mortality reduction in patients post-2010 with preserved EF (HR,